SUBSCRIBE
SUBSCRIBE

Roche

NEWS
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Drug Development
FDA Calls Roche’s Leukemia Drug a Breakthrough
July 28, 2017
 · 
2 min read
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Business
Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics
July 20, 2017
 · 
2 min read
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Drug Development
Uncertainty Hits as Roche is Dealt Multiple Clinical Trial Setbacks
July 19, 2017
 · 
3 min read
Merck & Co.'s Alzheimer's Contender Wows in Human Clinical Trial
Drug Development
Merck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche’s Failed
June 27, 2017
 · 
2 min read
Doing it Right: The Man Who Blew Up Theranos Started His Own Medical Testing Biotech
Job Trends
Roche’s Former New Jersey Site to Become a Life Sciences Campus
June 15, 2017
 · 
2 min read
Policy
Aspen Pharmacare, Pfizer and Roche Investigated For Excessive Cancer Drug Pricing In South Africa
June 14, 2017
 · 
1 min read
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Policy
Hundreds of Patient Deaths Linked to Roche’s RA Drug Actemra
June 7, 2017
 · 
4 min read
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Roche’s New MS Drug Linked to Deadly Brain Infection
May 25, 2017
 · 
2 min read
Bristol-Myers Squibb's Stock Topples as Kidney Cancer Drug Flunks Phase III Study
Business
Bristol-Myers Squibb Inks Two Separate Pacts With Biogen and Roche For a Total of Up to $1.1B
April 13, 2017
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Roche receives CE mark for new blood test to detect Alzheimer’s pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
May 12, 2026
 · 
10 min read
Press Releases
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
May 7, 2026
 · 
4 min read
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
 · 
15 min read
Press Releases
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
April 30, 2026
 · 
11 min read
Press Releases
Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management
April 29, 2026
 · 
6 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
April 23, 2026
 · 
20 min read
Press Releases
Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
April 22, 2026
 · 
15 min read
Press Releases
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
April 22, 2026
 · 
10 min read
Press Releases
Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD
April 22, 2026
 · 
12 min read
Press Releases
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
April 21, 2026
 · 
9 min read
Load More